Neurocrine Biosciences
NBIX
#1544
Rank
S$14.51 B
Marketcap
$145.63
Share price
-0.07%
Change (1 day)
-22.89%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend history for this company